Chargement en cours...
Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker
We review the pharmaceutical science of ethylphenidate (EPH) in the contexts of drug discovery; drug interactions; biomarker for dl-methylphenidate (MPH)-ethanol exposure; potentiation of dl-MPH abuse liability; contemporary “designer drug”; pertinence to the newer transdermal and chiral switch MPH...
Enregistré dans:
| Publié dans: | J Pharm Sci |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4237660/ https://ncbi.nlm.nih.gov/pubmed/25303048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.24202 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|